Fera acquires rights to investigational otomycosis treatment Decision Resources: Only half of payers support biosimilar substitution BioScrip inks cancer drug deal with Access PhRMA: 313 mental disorder treatments are in development WASHINGTON More than 300 medications for treating mental disorders are in development, according to a new report by a pharmaceutical industry lobbying group. J&J: Nucynta produced fewer side effects than competitor in trial Amgen gets priority review from FDA Kaletra-Isentress therapy for HIV patients as effective as standard treatments, drug makers say FDA accepts NDA for Eisai's Banzel Millipore officially becomes part of Merck KGaA Cardinal Health completes Healthcare Solutions Holding acquisition First Previous 185 186 187 188 189 Next Last